Clinical trial
The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device
NCT00766935 is registered in ClinicalTrials.gov with ImpediMed Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device
- Lead sponsor
- ImpediMed Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- April 30, 2008
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.